GSK2818713

broad geno. HCV NS5A repl. complex inhibitor

low Cl and orally available in higher species

from rational design from known ligand

J. Med. Chem., Apr. 23, 2020

GlaxoSmithKline, Research Triange Park, NC

GSK2818713 is an HCV NS5A replication complex inhibitor with an interesting biphenylene linker. The crowded, hotly competitive NS5A space has led to a lot of creative chemical scaffolds including this…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks